Status:
COMPLETED
Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
Lead Sponsor:
Jonsson Comprehensive Cancer Center
Collaborating Sponsors:
Kaiser Permanente
The Methodist Hospital Research Institute
Conditions:
Glioma
Glioblastoma
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
It was previously shown that 18F-DOPA PET imaging results in intended management changes in 41% of brain tumor patients. However, its impact on patient outcome defined as survival, costs, and/or quali...
Detailed Description
Malignant gliomas are aggressive primary brain tumors that almost always lead to rapid patient deterioration and death. Timely diagnosis of recurrent disease as well as accurate monitoring of therapeu...
Eligibility Criteria
Inclusion
- Suspected first recurrence of a glioblastoma tumor by clinical measures and/or MRI
- Age 18-99 years
Exclusion
- Breast feeding/ Pregnancy
- Severe psychiatric illness
- Primary diagnosis of a glioblastoma
Key Trial Info
Start Date :
August 22 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 14 2020
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT01813877
Start Date
August 22 2012
End Date
January 14 2020
Last Update
July 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA
Los Angeles, California, United States, 90095